Phil served as Chief Financial Officer and Vice President, Finance and Operations of Peplin, Inc. an Australian listed company.
Previously, Phil served as vice president, Finance and Operations at Chiron Corporation, a biotechnology company acquired by Novartis AG in 2006.
Chiron's Biopharmaceuticals business employed approximately 2,200 people and recorded revenue of $800 million and had a portfolio of R & D expenses of $300 million in 200.
From 1995 to his departure in April 206, Mr. Moody held positions of increasing seniority at Chiron, including Vice President of Finance and Chief Accounting Officer.
While in Biopharmaceuticals, Phil
was responsible for all financial aspects of the business, and during his
managed many other activities including collaboration management, manufacturing and process development, marketing and sales.
Phil has extensive experience as an executive in multiple industries, having been at IBM and ROLM in executive capacities and consulted with other companies, both public and private.